Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-08-07
2009-02-24
Shiao, Rei-Tsang (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S461000, C549S061000, C549S474000
Reexamination Certificate
active
07495024
ABSTRACT:
The method of treating patients be administering phenylalkyl N-hydroxurea derivatives for combating atherosclerotic plaque and cardiovascular diseases and compositions for this use.
REFERENCES:
patent: 5288751 (1994-02-01), Brooks et al.
patent: 2005/0113408 (2005-05-01), Helgadottir
patent: 2006/0019269 (2006-01-01), Helgadottir
The International Search Report and Written Opinion by the International Searching Authority, issued on May 27, 2008, in the PCT application No. PCT/US07/16030.
Cooper Melisa
Olukotun Adeoye
Quertermous Thomas
Tabibiazar Raymond
Coppins Janet L
Shiao Rei-Tsang
VIA Pharmaceuticals, Inc.
LandOfFree
Phenylalkyl N-hydroxyureas for combating atherosclerotic plaque does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenylalkyl N-hydroxyureas for combating atherosclerotic plaque, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenylalkyl N-hydroxyureas for combating atherosclerotic plaque will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4089557